Intracellular mediators of erucylphosphocholine-induced apoptosis

Oncogene

Volumn 22, Issue 17, 2003, Pages 2621-2632

  Jendrossek, Verena ^a   Müller, Ilka ^a   Eibl, Hansjörg ^b   Belka, Claus ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

Author keywords

Apoptosis; Bcl 2; Caspases; Erucylphosphocholine; FADD; Mitochondria

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 8; CASPASE 9; CYTOCHROME C; ERUCYLPHOSPHOCHOLINE; FAS ANTIGEN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHATIDYLSERINE; PHOSPHORYLCHOLINE; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CHROMATIN CONDENSATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DEPOLARIZATION; ENZYME ACTIVATION; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOMA CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; APOPTOSIS; BLOTTING, WESTERN; CARRIER PROTEINS; CASPASES; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; HUMANS; JURKAT CELLS; MITOCHONDRIA; PHOSPHORYLCHOLINE; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION;

EID: 0037516889     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206355     Document Type: Article

References (81)

1. Belka C and Budach W. (2002). Int. J. Radiat. Biol., 78, 643-658.
2. Belka C, Rudner J, Wesselborg S, Stepczynska A, Marini P, Lepple-Wienhues A, Faltin H, Bamberg M, Budach W and Schulze-Osthoff K. (2000). Oncogene, 19, 1181-1190.
3. Belka C, Schmid B, Marini P, Durand E, Rudner J, Faltin H, Bamberg M, Schulze-Osthoff K and Budach W. (2001). Oncogene, 20, 2190-2196.
4. Berger MR, Betsch B, Gebelein M, Amtmann E, Heyl P and Scherf HR. (1993). J. Cancer Res. Clin. Oncol., 119, 541-548.
5. Berggren MI, Gallegos A, Dressler LA, Modest EJ and Powis G. (1993). Cancer Res., 53, 4297-4302.
6. Bergmann J, Junghahn I, Brachwitz H and Langen P. (1994). Anticancer Res., 14, 1549-1556.
7. Berkovic D, Bensch M, Bertram J, Wille T, Haase D, Binder C and Fleer EA. (2001). Eur. J. Cancer, 37, 503-511.
8. Berkovic D, Grundel O, Berkovic K, Wildfang I, Hess CF and Schmoll HJ. (1997). Radiother. Oncol., 43, 293-301.
9. Berkovic D, Grunwald U, Menzel W, Unger C, Hiddemann W and Fleer EA. (1995). Eur. J. Cancer, 31A, 2080-2085.
10. Boldin MP, Goncharov TM, Goltsev YV and Wallach D. (1996). Cell, 85, 803-815.
11. Boldin MP, Mett IL, Varfolomeev EE, Chumakov I, Shemer-Avni Y, Camonis JH and Wallach D. (1995). J. Biol. Chem., 270, 387-391.
12. Cabaner C, Gajate C, Macho A, Munoz E, Modolell M and Mollinedo F. (1999). Br. J. Pharmacol., 127, 813-825.
13. Chen M and Wang J. (2002). Apoptosis, 7, 313-319.
14. Cheng EH, Wei MC, Weiler S, Flavell RA, Mak TW, Lindsten T and Korsmeyer SJ. (2001). Mol. Cell., 8, 705-711.
15. Cinek T, Hilgert I and Horejsi V. (1995). Immunogenetics, 41, 110-116.
16. Clive S, Gardiner J and Leonard RC. (1999). Cancer Chemother. Pharmacol., 44, S29-S30.
17. Cuvillier O, Mayhew E, Janoff AS and Spiegel S. (1999). Blood, 94, 3583-3592.
18. Daniel PT, Wieder T, Sturm I and Schulze-Osthoff K. (2001). Leukemia, 15, 1022-1032.
19. Engelmann J, Henke J, Willker W, Kutscher B, Nossner G, Engel J and Leibfritz D. (1996). Anticancer Res., 16, 1429-1439.
20. Engels IH, Stepczynska A, Stroh C, Lauber K, Berg C, Schwenzer R, Wajant H, Janicke RU, Porter AG, Belka C, Gregor M, Schulze-Osthoff K and Wesselborg S. (2000). Oncogene, 19, 4563-4573.
21. Erdlenbruch B, Jendrossek V, Gerriets A, Vetterlein F, Eibl H and Lakomek M. (1999). Cancer Chemother. Pharmacol., 44, 484-490.
22. Ergezinger K, Vehmeyer K and Unger C. (1999). Anticancer Res., 19, 3213-3219.
23. Ferrari D, Stepczynska A, Los M, Wesselborg S and Schulze-Osthoff K. (1998). J. Exp. Med., 188, 979-984.
24. Friesen C, Fulda S and Debatin KM. (1997). Leukemia, 11, 1833-1841.
25. Fulda S, Friesen C, Los M, Scaffidi C, Mier W, Benedict M, Nunez G, Krammer PH, Peter ME and Debatin KM. (1997). Cancer Res., 57, 4956-4964.
26. Gajate C, Fonteriz RI, Cabaner C, Alvarez-Noves G, Alvarez-Rodriguez Y, Modolell M and Mollinedo F. (2000). Int. J. Cancer, 85, 674-682.
27. Gajate C and Mollinedo F. (2001). Blood, 98, 3860-3863.
28. Gajate C, Santos-Beneit A, Modolell M and Mollinedo F. (1998). Mol. Pharmacol., 53, 602-612.
29. Georgieva MC, Konstantinov SM, Topashka-Ancheva M and Berger MR. (2002). Cancer Lett., 182, 163-174.
30. Grassme H, Jekle A, Riehle A, Schwarz H, Berger J, Sandhoff K, Kolesnick R and Gulbins E. (2001). J. Biol. Chem., 276, 20589-20596.
31. Hakem R, Hakem A, Duncan GS, Henderson JT, Woo M, Soengas MS, Elia A, de la Pompa JL, Kagi D, Khoo W, Potter J, Yoshida R, Kaufman SA, Lowe SW, Penninger JM and Mak TW. (1998). Cell, 94, 339-352.
32. Huang HW, Goldberg EM and Zidovetzki R. (1999). Biophys. J., 77, 1489-1497.
33. Jendrossek V, Erdlenbruch B, Hunold A, Kugler W, Eibl H and Lakomek M. (1999). Int. J. Oncol., 14, 15-22.
34. Jendrossek V, Kugler W, Erdlenbruch B, Eibl H, Lang F and Lakomek M. (2001). Anticancer Res., 21, 3389-3396.
35. Kharbanda S, Saxena S, Yoshida K, Pandey P, Kaneki M, Wang Q, Cheng K, Chen YN, Campbell A, Sudha T, Yuan ZM, Narula J, Weichselbaum R, Nalin C and Kufe D. (2000). J. Biol. Chem., 275, 322-327.
36. Konstantinov SM and Berger MR. (1999). Cancer Lett., 144, 153-160.
37. Konstantinov SM, Eibl H and Berger MR. (1998). Cancer Chemother. Pharmacol., 41, 210-216.
38. Li H, Zhu H, Xu CJ and Yuan J. (1998). Cell, 94, 491-501.
39. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES and Wang X. (1997). Cell, 91, 479-489.
40. Li X, Marani M, Mannucci R, Kinsey B, Andriani F, Nicoletti I, Denner L and Marcelli M. (2001). Cancer Res., 61, 1699-1706.
41. Lucas L, Hernandez-Alcoceba R, Penalva V and Lacal JC. (2001). Oncogene, 20, 1110-1117.
42. Luo X, Budihardjo I, Zou H, Slaughter C and Wang X. (1998). Cell, 94, 481-490.
43. Matzke A, Massing U and Krug HF. (2001). Eur. J. Cell Biol., 80, 1-10.
44. Micheau O, Solary E, Hammann A and Dimanche-Boitrel MT. (1999). J. Biol. Chem., 274, 7987-7992.
45. Miyashita T and Reed JC. (1993). Blood, 81, 151-157.
46. Mollinedo F, Fernandez-Luna JL, Gajate C, Martin-Martin B, Benito A, Martinez-Dalmau R and Modolell M. (1997). Cancer Res., 57, 1320-1328.
47. Mollinedo F, Gajate C and Modolell M. (1994). Biochem. J., 302, 325-329.
48. Muller M, Strand S, Hug H, Heinemann EM, Walczak H, Hofmann WJ, Stremmel W, Krammer PH and Galle PR. (1997). J. Clin. Invest., 99, 403-413.
49. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME and Dixit VM. (1996). Cell, 85, 817-827.
50. Newton K and Strasser A. (2000). J Exp Med, 191, 195-200.
51. Nomura Y, Inanami O, Takahashi K, Matsuda A and Kuwabara M. (2000). Leukemia, 14, 299-306.
52. Noseda A, Berens ME, White JG and Modest EJ. (1988). Cancer Res., 48, 1788-1791.
53. Noseda A, White JG, Godwin PL, Jerome WG and Modest EJ. (1989). Exp. Mol. Pathol., 50, 69-83.
54. Raisova M, Goltz G, Bektas M, Bielawska A, Riebeling C, Hossini AM, Eberle J, Hannun YA, Orfanos CE and Geilen CC. (2002). FEBS Lett., 516, 47-52.
55. Raisova M, Hossini AM, Eberle J, Riebeling C, Wieder T, Sturm I, Daniel PT, Orfanos CE and Geilen CC. (2001). J. Invest. Dermatol., 117, 333-340.
56. Rudner J, Belka C, Marini P, Wagner RJ, Faltin H, Lepple-Wienhues A, Bamberg M and Budach W. (2001a). Int. J. Radiat. Biol., 77, 1-11.
57. Rudner J, Jendrossek V and Belka C. (2002). Apoptosis, 7, 441-447.
58. Rudner J, Lepple-Wienhues A, Budach W, Berschauer J, Friedrich B, Wesselborg S, Schulze-Osthoff K and Belka C. (2001b). J. Cell Sci., 114, 4161-4172.
59. Ruiter GA, Verheij M, Zerp SF and van Blitterswijk WJ. (2001). Int. J. Radiat. Oncol. Biol. Phys., 49, 415-419.
60. Ruiter GA, Zerp SF, Bartelink H, van Blitterswijk WJ and Verheij M. (1999). Cancer Res., 59, 2457-2463.
61. Sakahira H, Enari M and Nagata S. (1998). Nature, 391, 96-99.
62. Salvesen GS and Dixit VM. (1997). Cell, 91, 443-446.
63. Salvesen GS and Dixit VM. (1999). Proc. Natl. Acad. Sci. USA, 96, 10964-10967.
64. Schulze-Osthoff K, Ferrari D, Los M, Wesselborg S and Peter ME. (1998). Eur. J. Biochem., 254, 439-459.
65. Smorenburg CH, Seynaeve C, Bontenbal M, Planting AS, Sindermann H and Verweij J. (2000). Anticancer Drugs, 11, 825-828.
66. Stekar J, Hilgard P and Klenner T. (1995). Eur. J. Cancer, 31A, 372-374.
67. Stepczynska A, Lauber K, Engels IH, Janssen O, Kabelitz D, Wesselborg S and Schulze-Osthoff K. (2001). Oncogene, 20, 1193-1202.
68. Stroh C and Schulze-Osthoff K. (1998). Cell Death Differ., 5, 997-1000.
69. Thornberry NA and Lazebnik Y. (1998). Science, 281, 1312-1316.
70. Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A, Bar-Sagi D, Jones SN, Flavell RA and Davis RJ. (2000). Science, 288, 870-874.
71. Unger C, Sindermann H, Peukert M, Hilgard P, Engel J and Eibl H. (1992). Prog. Exp. Tumor. Res., 34, 153-159.
72. Varfolomeev EE, Schuchmann M, Luria V, Chiannilkulchai N, Beckmann JS, Mett IL, Rebrikov D, Brodianski VM, Kemper OC, Kollet O, Lapidot T, Soffer D, Sobe T, Avraham KB, Goncharov T, Holtmann H, Lonai P and Wallach D. (1998). Immunity, 9, 267-276.
73. Vehmeyer K, Eibl H and Unger C. (1992). Exp. Hematol., 20, 1-5.
74. Verheij M, Bose R, Lin XH, Yao B, Jarvis WD, Grant S, Birrer M J, Szabo E, Zon LI, Kyriakis JM, Haimovitz-Friedman A, Fuks Z and Kolesnick RN. (1996). Nature, 380, 75-79.
75. Verweij J, Planting A, van der Burg M and Stoter G. (1992). J. Cancer Res. Clin. Oncol., 118, 606-608.
76. von Haefen C, Wieder T, Gillissen B, Starck L, Graupner V, Dorken B and Daniel PT. (2002). Oncogene, 21, 4009-4019.
77. Wesselborg S, Engels IH, Rossmann E, Los M and Schulze-Osthoff K. (1999). Blood, 93, 3053-3063.
78. Wieder T, Essmann F, Prokop A, Schmelz K, Schulze-Osthoff K, Beyaert R, Dorken B and Daniel PT. (2001). Blood, 97, 1378-1387.
79. Wieder T, Orfanos CE and Geilen CC. (1998). J. Biol. Chem., 273, 11025-11031.
80. Zheng B, Oishi K, Shoji M, Eibl H, Berdel WE, Hajdu J, Vogler WR and Kuo JF. (1990). Cancer Res, 50, 3025-3031.
81. Zou H, Li Y, Liu X and Wang X. (1999). J. Biol. Chem., 274, 11549-11556.